Outsourced Pharma Commercialization: Growth in a Dynamic Time

Business people working on financial data, graphs, and charts on a digital tablet.

HCLS Article Outsourced Pharma Commercialization Header

Harris-Williams Bio-Crop 0040 JulianFeneley 1

Managing Director

Profile

Harris-Williams Bio-Crop 0067 1421 PaulHepper

Harris-Williams Bio-Crop 0021 089 DanLinsalata

Harris-Williams Bio-Crop 0003 AndreyDvorkin

Director

HCLS Article Outsourced Pharma Commercialization LI web-media

TPG Makes Significant Strategic Growth Investment in K2 Medical Research

6516 TPG Growth - K2 Medical Research SP

Mergers & Acquisitions

IntegriChain Acquired by Nordic Capital   

5991 IntegriChain NT

Amulet Capital Partners Acquires Alliance Clinical Network

United States

5845 Alliance Clinical Network NT

Pharmalex

Germany

5543 Pharmalex (Project I) NT

Harris Williams advised Altasciences, a portfolio company of Audax Private Equity, on its sale to Novo Holdings. Founded in 1992, Altasciences is a fully integrated, early drug development services platform, providing the pharma and biotech industries with a trusted partner for drug development, from preclinical safety testing through to clinical proof-of-concept studies.

Altasciences

Canada

altasciences-project-helix.png

A leading contract development and manufacturing organization (CDMO) to the global pharmaceutical industry. 
 
 Has been acquired by Nautic Partners, Providence, Rhode Island

Mikart, Inc.

mikart-nautic.gif

The CM Group

5679 The CM Group

Harris Williams advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners. Jordi Labs is a leader in analytical chemistry testing, delivering a full suite of regulatory, investigative, and related services to the medical device, pharmaceutical, and other industries.

Jordi Labs

5663 Jordi Labs NT

Harris Williams advised Medical Knowledge Group, a portfolio company of Court Square, on its sale to Novo Holdings. Medical Knowledge Group is an analytics-driven drug commercialization platform serving the biopharmaceutical industry.

Medical Knowledge Group

5490_medical_knowledge_group_mkg.png

Harris Williams advised RQM+, a portfolio company of DFW Capital Partners and Chartwell Investments Entrepreneur & Founder Capital (Chief Capital), on its sale to Linden Capital Partners. RQM+ provides regulatory and quality consulting and engineering for medical devices, in vitro diagnostics and combination products.

RQM+

5282_rqm.png

Site Map

Privacy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Select Activity

Pharma Commercialization Solutions: IntegriChain Exemplifies the Opportunity

Outsourced Pharma Services & Pharma Tech Q2 2024

Return on Innovation: An Eight-Part Series

Select Activity

Related Insights

Pharma Commercialization Solutions: IntegriChain Exemplifies the Opportunity

Outsourced Pharma Services & Pharma Tech Q2 2024

Return on Innovation: An Eight-Part Series